The U.S. Food and Drug Administration today issued a draft guidance for sponsors seeking approval of human gene therapy products involving genome editing technologies.
FDA News Releases published a clinical update in Research Highlights on 14 Apr 2026. The item focuses on FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development. Open the detail page to review the full original feed content.